Review Article

Mindfulness-Based Therapies in the Treatment of Functional Gastrointestinal Disorders: A Meta-Analysis

Table 1

Characteristics and outcomes of studies included in systematic review.

Study, % femalePopulationIntervention & durationControlFollow-upIBS severity at end-of-interventionIBS severity at follow-upQuality of life

Berrill et al. 2014 [14]38, 77%IBD with IBS-type symptomsMCT; 16 weeks Waiting list (TAU)8 and 12 monthsDecrease in IBS-SS but did not reach statistical significance (32.5% vs. 6.8% reduction, )Decrease in IBS-SS but did not reach statistical significance (30.0% vs. 0% reduction, )Not assessed

Gaylord et al. 2011 [15]75, 100%IBSMindfulness-based stress and pain management program; 8 weeksSupport group3 monthsSignificantly greater improvement in IBS-SS (26.4 vs. 6.2% reduction, )Improvement maintained (38.2 vs. 11.8% reduction, )Significant improvement in IBS-QOL at follow-up only ()

Ljtsson et al. 2010 [16]85, 85%IBSICBT, 10 weeksOnline closed discussion forum 3 monthsSignificant improvement in diary symptom ratings (pain, diarrhea, constipation, and bloating) and GSRS-IBS (42% reduction vs. 12% increase, )Improvement in GSRS-IBS maintained Significant improvement in IBS-QOL post treatment (); further significant improvement at follow-up ()

Ljtsson et al. 2011 [17]Long term follow-up of Ljtsson et al. (2010) [16]15–18 (mean = 16.4) monthsImprovement in GSRS-IBS maintained ()Significant improvement in IBS-QOL (), maintained at follow-up; no difference between those who did/did not seek additional care for IBS

Ljtsson et al. 2011 [18]61, 74%IBSICBT, 10 weeksOnline closed discussion forum before crossing over12 monthsSignificantly larger improvement in GSRS-IBS (30.5% reduction vs. 2.8% increase) (Cohen’s 0.77 (0.19–1.34 95% CI))Improvement in GSRS-IBS maintainedSignificantly greater improvement in IBS-QOL (Cohen’s 0.79 (0.20–1.35 95% CI)); further improvement at follow-up ()

Ljtsson et al. 2011 [19]195, 79%IBSICBT, 10 weeksInternet-based stress management6 monthsSignificantly larger improvement in GSRS-IBS (23.6% vs. 13.1% reduction) (difference in score of 4.8 (1.2–8.4 95% CI))Significantly larger improvement in GSRS-IBS (difference in score of 5.9 (1.9–9.9 95% CI)); nonsignificant trend towards continued improvementSignificantly larger improvement in IBS-QOL (difference in score of 10 (4.5–15.6 95% CI)), maintained at follow-up (difference in score of 6.2 (0.2–12.2 95% CI))

Zernicke et al. 2013 [20]90, 90%IBSMBSR; 8 weeksTAU waitlist6 monthsSignificantly greater improvement in IBS-SS (30.7 vs. 5.2% reduction among completers, 16.9% vs. 3.5% using ITT)Improvement maintained; some improvement seen in TAU group leading to no statistically significant difference () IBS-QOL improved in both groups posttreatment and follow-up ()

Zomorodi et al. 2014 [21]48, 44%IBS and healthy controlsMBSR or CBT, 8 weeksNo psychological intervention2 monthsNot providedSignificantly greater improvement in IBS questionnaire vs. CBT or control (35.0% vs. 5.8%, )Not assessed

GSRS-IBS: gastrointestinal symptom rating scale—IBS version.
ICBT: internet-based cognitive behavior therapy which includes exposure, mindfulness, and acceptance.
IBS-SS: irritable bowel syndrome severity score.
IBDQ: inflammatory bowel disease questionnaire.
IBS-QOL: irritable bowel syndrome quality of life instrument.
MCT: multiconvergent therapy-combination of mindfulness meditation and CBT.
MBSR: mindfulness-based stress reduction.
TAU: treatment as usual.